Investor Relations LatestPress Releases Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model Mar 07, 2023 Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price Feb 28, 2023 Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022 btn News IR View All RecentEvents Feb 28, 2023 28 Feb 2023 at 8:30 AM EST Fourth-Quarter Fiscal 2022 Financial Results Conference Call Listen to Webcast Oct 13, 2022 13 Oct 2022 at 8:30 AM EDT Third-Quarter Fiscal 2022 Financial Results Conference Call Listen to Webcast Sep 28, 2022 28 Sep 2022 at 9:00 AM EDT Cantor Oncology, Hematology & HemeOnc Conference btn Events View All Financial InformationLatest Earnings Show all Q3 2022 Financial Statement 871 KB MD&A 397.9 KB btn QRs View More PresentationsInvestor Presentation Download PDF
Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Feb 28, 2023 Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
Feb 28, 2023 28 Feb 2023 at 8:30 AM EST Fourth-Quarter Fiscal 2022 Financial Results Conference Call Listen to Webcast
Oct 13, 2022 13 Oct 2022 at 8:30 AM EDT Third-Quarter Fiscal 2022 Financial Results Conference Call Listen to Webcast